BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 9577584)

  • 1. [Diagnosis and therapy of chronic myeloproliferative disorders].
    Kimura A
    Nihon Naika Gakkai Zasshi; 1998 Mar; 87(3):507-12. PubMed ID: 9577584
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular genetic evaluation of myeloproliferative neoplasms.
    Azzato EM; Bagg A
    Int J Lab Hematol; 2015 May; 37 Suppl 1():61-71. PubMed ID: 25976962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic myeloproliferative neoplasms in the elderly.
    Maffioli M; Orlandi E; Passamonti F
    Eur J Intern Med; 2018 Dec; 58():33-42. PubMed ID: 29793825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Chronic myeloproliferative diseases. New knowledge about well known diseases].
    Aulitzky WE; Griesshammer M; Heimpel H; Huhn D
    Dtsch Med Wochenschr; 1996 May; 121(18):600-4. PubMed ID: 8625788
    [No Abstract]   [Full Text] [Related]  

  • 5. [Chronic myeloproliferative syndromes].
    de Ozalla CB; García Suárez J
    Rev Clin Esp; 1999 Apr; 199 Suppl 1():28-36. PubMed ID: 10422448
    [No Abstract]   [Full Text] [Related]  

  • 6. Chronic myeloproliferative disorders: the role of tyrosine kinases in pathogenesis, diagnosis and therapy.
    Macdonald D; Cross NC
    Pathobiology; 2007; 74(2):81-8. PubMed ID: 17587879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The myeloproliferative disorders.
    Gilbert HS; Dameshek W
    Dis Mon; 1970 Oct; ():1-52. PubMed ID: 4921953
    [No Abstract]   [Full Text] [Related]  

  • 8. Pediatric Myeloproliferative Neoplasms.
    El-Sharkawy F; Margolskee E
    Clin Lab Med; 2021 Sep; 41(3):529-540. PubMed ID: 34304780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Myeloproliferative disorders].
    Binder D; Fehr J
    Ther Umsch; 2004 Feb; 61(2):131-42. PubMed ID: 15018396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone marrow biopsy (BMB). II. Bone marrow biopsy in myeloproliferative disorders.
    Macavei I; Galatâr N
    Morphol Embryol (Bucur); 1989; 35(2):117-27. PubMed ID: 2529429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myeloproliferative neoplasms.
    Publicover A; Medd P
    Clin Med (Lond); 2013 Apr; 13(2):188-92. PubMed ID: 23681871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prognostic value of bone marrow biopsy in chronic myeloproliferative disorders].
    Bettini R; Marzetta K; Miglioranza A; Redaelli S; Maino C; Maffiolini A; Gorini M
    Recenti Prog Med; 2003; 94(7-8):314-20. PubMed ID: 12868237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnosis and treatment of BCR/ABL-negative myeloproliferative diseases--principles and rationale of CZEMP recommendations].
    Schwarz J; Penka M; Campr V; Pospísilová D; Kren L; Nováková L; Bodzásová C; Brychtová Y; Cerná O; Dulícek P; Joniásová A; Kissová J; Korístek Z; Schützová M; Vonke I; Walterová L
    Vnitr Lek; 2011 Feb; 57(2):189-213. PubMed ID: 21416861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment strategy for myeloproliferative neoplasms].
    Yoshimoto G; Miyamoto T
    Rinsho Ketsueki; 2014 Oct; 55(10):1841-52. PubMed ID: 25297748
    [No Abstract]   [Full Text] [Related]  

  • 15. The diagnosis and management of polycythemia vera, essential thrombocythemia, and primary myelofibrosis in the JAK2 V617F era.
    Zhan H; Spivak JL
    Clin Adv Hematol Oncol; 2009 May; 7(5):334-42. PubMed ID: 19521323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of CALR Mutation in Clonal and Nonclonal Hematologic Diseases Using Fragment Analysis and Next-Generation Sequencing.
    Gardner JA; Peterson JD; Turner SA; Soares BL; Lancor CR; Dos Santos LL; Kaur P; Ornstein DL; Tsongalis GJ; de Abreu FB
    Am J Clin Pathol; 2016 Oct; 146(4):448-55. PubMed ID: 27686171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The management of elderly patients with myeloproliferative disorders.
    Tura S
    Hematol Oncol; 1993; 11 Suppl 1():39-41. PubMed ID: 8486340
    [No Abstract]   [Full Text] [Related]  

  • 18. The role of beta-catenin in chronic myeloproliferative disorders.
    Jauregui MP; Sanchez SR; Ewton AA; Rice L; Perkins SL; Dunphy CH; Chang CC
    Hum Pathol; 2008 Oct; 39(10):1454-8. PubMed ID: 18619646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis and management of myeloproliferative disorders.
    Laszlo J; Huang AT
    Curr Probl Cancer; 1977 Jul; 2(1):1-42. PubMed ID: 268266
    [No Abstract]   [Full Text] [Related]  

  • 20. Myeloproliferative neoplasms: A decade of discoveries and treatment advances.
    Tefferi A
    Am J Hematol; 2016 Jan; 91(1):50-8. PubMed ID: 26492355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.